PROSTAR 9 FR. PERCUTANEOUS VASCULAR SURGICAL (PVS) SYSTEM
Abbott Vascular, Inc. · Decision date Apr 30, 1997
What did the FDA approve?
The FDA approved the PROSTAR 9 Fr. Percutaneous Vascular Surgical (PVS) System on April 30, 1997, under PMA number P960043. The system includes the PROSTAR PVS device in 9 and 11 French sizes, a pre-dilator in the same sizes, a Perclose knot pusher, a PROSTAR transition guidewire, and a Perclose arterial tamper.
According to the dated FDA statement, the system is indicated for percutaneous delivery of sutures to close the common femoral artery access site and reduce time to hemostasis and ambulation (time-to-standing) in patients who have undergone interventional procedures using 8 to 11 French sheaths. The statement does not include clinical data or independent proof of safety or effectiveness.
FDA approval order statement
APPROVAL FOR THE PROSTAR(R) PERCUTANEOUS VASCULAR SURGICAL (PVS) SYSTEM. THE PROSTAR(R) PVS SYSTEM CONSISTS OF THE PROSTAR(R) PVS DEVICE (9 AND 11 FRENCH SIZES) AND THE FOLLOWING ACCESSORIES: A PROSTAR(R) PRE-DILATOR (9 AND 11 FRENCH SIZES), A PERCLOSE(R) KNOT PUSHER, AND PROSTAR(R) TRANSITION GUIDEWIRE, AND A PERCLOSE(R) ARTERIAL TAMPER. THE PROSTAR(R) PVS SYSTEM IS INDICATED FOR THE PERCUTANEOUS DELIVERY OF SUTURES FOR CLOSING THE COMMON FEMORAL ARTERY ACCESS SITE ANC REDUCING THE TIME TO HEMOSTASIS AND AMBULATION (TIME-TO-STANDING) OF PATIENTS WHO HAVE UNDERGONE INTERVENTIONAL PROCEDURES USING 8 TO 11 FRENCH SHEATHS
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Apr 30, 1997
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P960043
- Regulatory pathway
- Premarket approval application
- Applicant
- Abbott Vascular, Inc.
- Product code
- MGB
- Decision code
- APPR
- Decision date
- Apr 30, 1997
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Device, hemostasis, vascular.
- Applicant
- Abbott Vascular, Inc.
- Product code
- MGB
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P960043 received
Application receipt date recorded by FDA.
P960043 · FDA decision
APPR
P960043/S137 · Related supplement
Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System
P960043/S138 · Related supplement
Perclose ProStyle Suture-Mediated Closure and Repair System
P960043/S139 · Related supplement
Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System
Timeline entries are records held by MedtechLedger for P960043. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P960043
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Abbott Vascular, Inc. | PMA supplement | Sep 24, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Oct 26, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Nov 4, 2026 | FDA |
Explore the linked device profile
Other records with product code MGB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CELT ACD VASCULAR CLOSURE DEVICEP150006/S009 | Vasorum, Ltd. | PMA supplement | Oct 30, 2026 | FDA |
| Vivasure Medical , Ltd. | PMA approval | Oct 16, 2026 | FDA | |
VASCADE 5F Vascular Closure SystemP120016/S043 | Cardiva Medical, Inc. | PMA supplement | Sep 10, 2026 | FDA |
| Vasorum, Ltd. | PMA approval | Jul 20, 2016 | FDA | |
| Cardiva Medical, Inc. | PMA approval | Jan 31, 2013 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Vascular, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 400 Saginaw Dr., Redwood, CA, 94063
Sources and methodology
- Original FDA record: P960043
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



